WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Insulin

Governed registry record

6 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. Exercise and insulin resistance in type 2 diabetes mellitus: A systematic review and meta-analysis.

    DOI: 10.1016/j.rehab.2018.11.001PMID: 30553010

    Source identity and connection checked by Codex (AI).

  2. Hindbrain insulin controls feeding behavior.

    DOI: 10.1016/j.molmet.2022.101614PMID: 36244663

    Source identity and connection checked by Codex (AI).

  3. Human ultralente insulin.

    DOI: 10.1136/bmj.288.6418.665PMID: 6421424

    Source identity and connection checked by Codex (AI).

  4. Methamphetamine-induced insulin release.

    DOI: 10.1126/science.174.4004.66PMID: 5120870

    Source identity and connection checked by Codex (AI).

  5. Orforglipron, an oral non-peptide glucagon-like peptide-1 receptor agonist, improves markers of β-cell function and insulin sensitivity in type 2 diabetes.

    DOI: 10.1111/dom.70022PMID: 40808573

    Source identity and connection checked by Codex (AI).

  6. Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly.

    DOI: 10.2337/dc25-2041PMID: 41778920

    Source identity and connection checked by Codex (AI).